GLP-1 agonists work by mimicking the GLP-1 hormone, which is naturally released into the small intestine after a person eats
Bottom Line Semaglutide's pancreatitis risk is real but rare, and the science continues to trend in a reassuring direction
Wound macrophages as key regulators of repair: origin, phenotype, and function
Organizations focused on scalability often prefer structured sourcing solutions that accommodate future volume increases without sacrificing consistency
The trial record includes STEP (semaglutide for weight management, The New England Journal of Medicine , 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)